In healthy older adults, one night of normal sleep raises levels of amyloid-beta and tau proteins in the blood the next morning compared to a night without sleep, and this increase is largest in people who do not have amyloid buildup in their brains.
See the scientific wording
In healthy older adults, one night of normal sleep compared to sleep deprivation increases morning plasma levels of amyloid-beta (Aβ40, Aβ42) and tau proteins (np-tau181, np-tau217, p-tau181), with the greatest increase observed in individuals without amyloid pathology.
Very strong evidence
Randomized trialsOne good-quality study supports this claim.
What the research says
1 study reviewedSupporting (1)
The glymphatic system clears amyloid beta and tau from brain to plasma in humans
Randomized Controlled TrialHuman2026
When people sleep, their brain flushes out harmful proteins like amyloid-beta and tau into the blood—more so than when they stay awake all night. This cleaning effect is strongest in people who don’t yet have Alzheimer’s brain plaques.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
During sleep, the brain's fluid spaces expand and blood vessels pulse more strongly, allowing clean fluid to flow through the brain and carry away waste proteins like amyloid-beta and tau. These proteins enter the bloodstream, where their levels rise in the morning. This process works best in people whose brains have not yet developed plaques.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In healthy older adults, one night of normal sleep raises levels of amyloid-beta and tau proteins in the blood the next morning compared to a night without sleep, and this increase is largest in people who do not have amyloid buildup in their brains.
Mechanism
1 studyDuring sleep, the brain flushes out waste proteins like amyloid-beta and tau by expanding fluid channels and using blood vessel pulses to push them into the bloodstream. When awake, neurons release more of these proteins, but without the flush, they don’t clear as well. This cleanup works best in people whose brains haven’t started forming plaques.
During sleep, the brain's fluid spaces expand and blood vessels pulse more strongly, allowing clean fluid to flow through the brain and carry away waste proteins like amyloid-beta and tau. These proteins enter the bloodstream, where their levels rise in the morning. This process works best in people whose brains have not yet developed plaques.
Sleep induces synchronized low-frequency neural activity that reduces noradrenergic signaling and promotes vasodilation in cerebral vessels.
Reduced noradrenergic tone decreases brain parenchymal resistance, expanding the extracellular space and enabling greater influx of cerebrospinal fluid into the brain interstitial compartment.
Increased cerebrovascular compliance enhances pulsatile forces that drive cerebrospinal fluid along perivascular pathways into the interstitial space.
Cerebrospinal fluid mixes with interstitial fluid, convectively transporting amyloid-beta and tau solutes toward perivascular and meningeal drainage routes.
Amyloid-beta and tau solutes exit the brain via perivascular and meningeal lymphatic pathways and enter the systemic plasma.
The relative increase in aggregation-prone species (Aβ42, p-tau181, p-tau217) over non-aggregation-prone species (Aβ40, np-tau181, np-tau217) reflects selective clearance of these forms during sleep.
Less supported by current evidence, but not ruled out
When awake, neurons fire more frequently and release more amyloid-beta and tau proteins into the brain fluid. Without the flushing action of sleep, these proteins accumulate and their plasma levels rise less than during sleep, especially for the forms that aggregate into plaques.
Wakefulness increases neuronal activity and synaptic release of amyloid precursor protein and tau into the interstitial fluid.
Elevated interstitial concentrations of amyloid-beta and tau during wakefulness favor diffusion and passive transport into cerebrospinal fluid and plasma.
Without enhanced glymphatic flow, clearance of aggregation-prone species (Aβ42, p-tau) is limited, leading to a relative increase in non-aggregation-prone species (Aβ40, np-tau) in plasma.
Evidence from Studies
Supporting (1)
Community contributions welcome
The glymphatic system clears amyloid beta and tau from brain to plasma in humans
When people sleep, their brain flushes out harmful proteins like amyloid-beta and tau into the blood—more so than when they stay awake all night. This cleaning effect is strongest in people who don’t yet have Alzheimer’s brain plaques.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Sleep Deprivation and Plasma Amyloid-Beta and Tau Levels in Older Adults
Population: Healthy older adults; Intervention: One night of normal sleep; Comparator: One night of sleep deprivation; Outcome: Plasma levels of Aβ40, Aβ42, np-tau181, np-tau217, p-tau181; Duration: Single-night comparison across studies.
Double-Blind Crossover Trial of Sleep vs. Sleep Deprivation on Plasma Amyloid-Beta and Tau in Healthy Older Adults
Population: Healthy older adults; Intervention: One night of normal sleep; Comparator: One night of sleep deprivation; Outcome: Plasma levels of Aβ40, Aβ42, np-tau181, np-tau217, p-tau181 measured in the morning; Duration: Two conditions per participant in crossover design with washout period.
Prospective Cohort Study of Sleep Patterns and Plasma Biomarker Levels in Healthy Older Adults Over Multiple Nights
Population: Healthy older adults; Intervention: Natural variation in sleep duration and quality; Comparator: Sleep-deprived vs. well-slept individuals; Outcome: Plasma levels of Aβ40, Aβ42, np-tau181, np-tau217, p-tau181; Duration: Single-night measurements across a cohort.
In Vitro Model of Glymphatic Flow and Amyloid-Beta/Tau Clearance Under Simulated Sleep and Wake Conditions
Population: Human astrocyte and neuronal cell lines; Intervention: Fluid flow conditions simulating sleep; Comparator: Fluid flow conditions simulating wakefulness; Outcome: Clearance rates of Aβ40, Aβ42, np-tau181, np-tau217, p-tau181; Duration: Continuous monitoring over 6–12 hours.
Mouse Model Study of Sleep Deprivation and Plasma Amyloid-Beta/Tau Levels with Glymphatic Imaging
Population: Transgenic mice expressing human amyloid-beta and tau; Intervention: One night of sleep deprivation; Comparator: One night of normal sleep; Outcome: Plasma levels of Aβ40, Aβ42, np-tau181, np-tau217, p-tau181 and glymphatic flow via imaging; Duration: Single-night intervention with immediate post-intervention sampling.